hoe 166 has been researched along with bepridil in 1 studies
*Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. [MeSH]
*Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. [MeSH]
| Studies (hoe 166) | Trials (hoe 166) | Recent Studies (post-2010) (hoe 166) | Studies (bepridil) | Trials (bepridil) | Recent Studies (post-2010) (bepridil) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 798 | 70 | 94 |
| Protein | Taxonomy | hoe 166 (IC50) | bepridil (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 1.4 | |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 1 | |
| Lethal factor | Bacillus anthracis | 4.8 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 1 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.5184 | |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 1 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 1.2 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 3.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barhanin, J; Henning, R; Lazdunski, M; Lerch, U; Oekonomopulos, R; Qar, J; Romey, G; Urbach, H | 1 |
1 other study(ies) available for hoe 166 and bepridil
| Article | Year |
|---|---|
A novel high affinity class of Ca2+ channel blockers.
Topics: Animals; Bepridil; Binding Sites; Calcium Channel Blockers; Cell Line; Dihydropyridines; Fluspirilene; Isradipine; Kinetics; Muscles; Oxadiazoles; Piperidines; Pyrrolidines; Rabbits; Rats; Structure-Activity Relationship; Thiazines; Verapamil | 1988 |